Impact of COVID-19 on Congenital Heart Disease Management

Summary

The advent of COVID-19 has profoundly altered the clinical management landscape for individuals with congenital heart disease (CHD). Early in the pandemic, constraints on healthcare resources prompted the postponement of elective procedures and the reorganisation of surgical lists to prioritise urgent cases. Routine outpatient visits were transformed by telemedicine platforms to maintain continuity of care while minimising infection risk. Concurrently, risk stratification frameworks were developed to identify patients at greatest peril of adverse outcomes, taking into account anatomical complexity, comorbidities and social determinants of health. Vaccination campaigns introduced a critical protective measure, though concerns persisted regarding residual vulnerability among vaccinated CHD cohorts. Moreover, the pandemic stimulated research into the pathophysiology of SARS-CoV-2 in the context of developing cardiac structures and the influence of viral infection on long-term cardiac function. Collectively, these shifts underscore an evolving paradigm in which multidisciplinary coordination, remote monitoring and targeted prevention strategies safeguard this high-risk population in a landscape challenged by recurring viral waves.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Impact of COVID-19 on Congenital Heart Disease Management publication trend

The graph below shows the total number of articles in impact of covid-19 on congenital heart disease management across all publications each year (not limited to Nature Index journals).

Technical terms

Congenital heart disease (CHD): A spectrum of structural heart anomalies present at birth, ranging from simple septal defects to complex malformations.

SARS-CoV-2: The novel coronavirus responsible for COVID-19, which primarily targets the respiratory tract but can also affect the cardiovascular system.

Case-control study: An observational design that compares individuals with a specific outcome (cases) to those without (controls) to identify associated factors.

Retrospective cohort study: A research method that analyses historical data from a defined group of individuals to evaluate the relationship between exposures and outcomes.

References

  1. The impact of COVID-19 vaccination on patients with congenital heart disease in England: a case-control study. Heart (2024).
  2. Mortality and Complications of COVID-19 Among Adult Congenital Heart Disease Patients: A Retrospective Cohort Study Using the National Inpatient Sample Database. Current Problems in Cardiology (2023).
  3. COVID‐19 in Children with Congenital Heart Diseases: A Multicenter Case Series from Iran. Case Reports in Pediatrics (2021).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.